DXR
DXR
NASDAQ · Health Care

Daxor Corp

$11.35
+0.34 (+3.09%)
As of Sep 28, 10:27 PM ET ·
Financial Highlights (FY 2026)
Revenue
31.3K
Net Income
10.69M
Gross Margin
-3,917.2%
Profit Margin
34,356.6%
Rev Growth
-51.2%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -3,917.2% -3,917.2% 65.2% 65.2%
Operating Margin -4,207.4% -3,786.7% 7.4% 8.1%
Profit Margin 34,356.6% 32,638.8% 8.7% 8.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 31.3K 64.1K 9.97M 8.80M
Gross Profit -1,224,212 -2,509,659 6.50M 5.73M
Operating Income -1,314,890 -2,425,996 732.9K 708.7K
Net Income 10.69M 19.72M 867.5K 729.9K
Gross Margin -3,917.2% -3,917.2% 65.2% 65.2%
Operating Margin -4,207.4% -3,786.7% 7.4% 8.1%
Profit Margin 34,356.6% 32,638.8% 8.7% 8.3%
Rev Growth -51.2% -51.2% +5.8% +5.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 18.88M 19.53M
Total Equity — — 43.47M 48.13M
D/E Ratio — — 0.43 0.41
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,308,474 -2,548,278 1.16M 1.05M
Free Cash Flow — — 750.2K 584.3K